333 related articles for article (PubMed ID: 27806086)
1. In Vitro and In Vivo Antitumor Activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in Malignant Pleural Mesothelioma.
Muscella A; Vetrugno C; Cossa LG; Antonaci G; De Nuccio F; De Pascali SA; Fanizzi FP; Marsigliante S
PLoS One; 2016; 11(11):e0165154. PubMed ID: 27806086
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis by [Pt(O,O'-acac)(γ-acac)(DMS)] requires PKC-δ mediated p53 activation in malignant pleural mesothelioma.
Muscella A; Vetrugno C; Cossa LG; Antonaci G; Barca A; De Pascali SA; Fanizzi FP; Marsigliante S
PLoS One; 2017; 12(7):e0181114. PubMed ID: 28704484
[TBL] [Abstract][Full Text] [Related]
3. The signalling axis mediating neuronal apoptosis in response to [Pt(O,O'-acac)(γ-acac)(DMS)].
Muscella A; Calabriso N; Vetrugno C; Fanizzi FP; De Pascali SA; Marsigliante S
Biochem Pharmacol; 2011 Jun; 81(11):1271-85. PubMed ID: 21420390
[TBL] [Abstract][Full Text] [Related]
4. [Pt(O,O'-acac)(gamma-acac)(DMS)], a new Pt compound exerting fast cytotoxicity in MCF-7 breast cancer cells via the mitochondrial apoptotic pathway.
Muscella A; Calabriso N; Fanizzi FP; De Pascali SA; Urso L; Ciccarese A; Migoni D; Marsigliante S
Br J Pharmacol; 2008 Jan; 153(1):34-49. PubMed ID: 18026127
[TBL] [Abstract][Full Text] [Related]
5. Different apoptotic effects of [Pt(O,O'-acac)(γ-acac)(DMS)] and cisplatin on normal and cancerous human epithelial breast cells in primary culture.
Vetrugno C; Muscella A; Fanizzi FP; Cossa LG; Migoni D; De Pascali SA; Marsigliante S
Br J Pharmacol; 2014 Nov; 171(22):5139-53. PubMed ID: 24990093
[TBL] [Abstract][Full Text] [Related]
6. Trabectedin Is Active against Malignant Pleural Mesothelioma Cell and Xenograft Models and Synergizes with Chemotherapy and Bcl-2 Inhibition In Vitro.
Hoda MA; Pirker C; Dong Y; Schelch K; Heffeter P; Kryeziu K; van Schoonhoven S; Klikovits T; Laszlo V; Rozsas A; Ozsvar J; Klepetko W; Döme B; Grusch M; Hegedüs B; Berger W
Mol Cancer Ther; 2016 Oct; 15(10):2357-2369. PubMed ID: 27512118
[TBL] [Abstract][Full Text] [Related]
7. Response of Cisplatin Resistant Skov-3 Cells to [Pt(
De Castro F; Benedetti M; Antonaci G; Del Coco L; De Pascali SA; Muscella A; Marsigliante S; Fanizzi FP
Molecules; 2018 Sep; 23(9):. PubMed ID: 30205612
[TBL] [Abstract][Full Text] [Related]
8. The essential role of the mitochondria and reactive oxygen species in Cisplatin-mediated enhancement of fas ligand-induced apoptosis in malignant pleural mesothelioma.
Stewart JH; Tran TL; Levi N; Tsai WS; Schrump DS; Nguyen DM
J Surg Res; 2007 Jul; 141(1):120-31. PubMed ID: 17574045
[TBL] [Abstract][Full Text] [Related]
9. [Pt(
Antonaci G; Cossa LG; Muscella A; Vetrugno C; De Pascali SA; Fanizzi FP; Marsigliante S
Biomolecules; 2019 Mar; 9(3):. PubMed ID: 30845773
[TBL] [Abstract][Full Text] [Related]
10. Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma.
Villanova T; Gesmundo I; Audrito V; Vitale N; Silvagno F; Musuraca C; Righi L; Libener R; Riganti C; Bironzo P; Deaglio S; Papotti M; Cai R; Sha W; Ghigo E; Schally AV; Granata R
Proc Natl Acad Sci U S A; 2019 Feb; 116(6):2226-2231. PubMed ID: 30659154
[TBL] [Abstract][Full Text] [Related]
11. PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma.
Kanteti R; Riehm JJ; Dhanasingh I; Lennon FE; Mirzapoiazova T; Mambetsariev B; Kindler HL; Salgia R
Sci Rep; 2016 Sep; 6():32992. PubMed ID: 27623107
[TBL] [Abstract][Full Text] [Related]
12. Sublethal concentrations of the platinum(II) complex [Pt(O,O'-acac)(gamma-acac)(DMS)] alter the motility and induce anoikis in MCF-7 cells.
Muscella A; Calabriso N; Vetrugno C; Urso L; Fanizzi FP; De Pascali SA; Marsigliante S
Br J Pharmacol; 2010 Jul; 160(6):1362-77. PubMed ID: 20590627
[TBL] [Abstract][Full Text] [Related]
13. PKC-δ/PKC-α activity balance regulates the lethal effects of cisplatin.
Muscella A; Vetrugno C; Antonaci G; Cossa LG; Marsigliante S
Biochem Pharmacol; 2015 Nov; 98(1):29-40. PubMed ID: 26300055
[TBL] [Abstract][Full Text] [Related]
14. Trametinib plus 4-Methylumbelliferone Exhibits Antitumor Effects by ERK Blockade and CD44 Downregulation and Affects PD-1 and PD-L1 in Malignant Pleural Mesothelioma.
Cho H; Matsumoto S; Fujita Y; Kuroda A; Menju T; Sonobe M; Kondo N; Torii I; Nakano T; Lara PN; Gandara DR; Date H; Hasegawa S
J Thorac Oncol; 2017 Mar; 12(3):477-490. PubMed ID: 27867002
[TBL] [Abstract][Full Text] [Related]
15. Antitumour and antiangiogenic activities of [Pt(O,O'-acac)(γ-acac)(DMS)] in a xenograft model of human renal cell carcinoma.
Muscella A; Vetrugno C; Biagioni F; Calabriso N; Calierno MT; Fornai F; De Pascali SA; Marsigliante S; Fanizzi FP
Br J Pharmacol; 2016 Sep; 173(17):2633-44. PubMed ID: 27351124
[TBL] [Abstract][Full Text] [Related]
16. Synergistic targeting of malignant pleural mesothelioma cells by MDM2 inhibitors and TRAIL agonists.
Urso L; Cavallari I; Silic-Benussi M; Biasini L; Zago G; Calabrese F; Conte PF; Ciminale V; Pasello G
Oncotarget; 2017 Jul; 8(27):44232-44241. PubMed ID: 28562336
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo therapeutic efficacy of the PPAR-γ agonist troglitazone in combination with cisplatin against malignant pleural mesothelioma cell growth.
Hamaguchi N; Hamada H; Miyoshi S; Irifune K; Ito R; Miyazaki T; Higaki J
Cancer Sci; 2010 Sep; 101(9):1955-64. PubMed ID: 20608936
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in mouse xenograft model of breast cancer.
Muscella A; Vetrugno C; Migoni D; Biagioni F; Fanizzi FP; Fornai F; De Pascali SA; Marsigliante S
Cell Death Dis; 2014 Jan; 5(1):e1014. PubMed ID: 24457958
[TBL] [Abstract][Full Text] [Related]
19. New platinum(II) complexes containing both an O,O'-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells.
Muscella A; Calabriso N; De Pascali SA; Urso L; Ciccarese A; Fanizzi FP; Migoni D; Marsigliante S
Biochem Pharmacol; 2007 Jun; 74(1):28-40. PubMed ID: 17481588
[TBL] [Abstract][Full Text] [Related]
20. Nintedanib Is Active in Malignant Pleural Mesothelioma Cell Models and Inhibits Angiogenesis and Tumor Growth
Laszlo V; Valko Z; Kovacs I; Ozsvar J; Hoda MA; Klikovits T; Lakatos D; Czirok A; Garay T; Stiglbauer A; Helbich TH; Gröger M; Tovari J; Klepetko W; Pirker C; Grusch M; Berger W; Hilberg F; Hegedus B; Dome B
Clin Cancer Res; 2018 Aug; 24(15):3729-3740. PubMed ID: 29724868
[No Abstract] [Full Text] [Related]
[Next] [New Search]